riTUXimab
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Genetic Implications: 
Pronunciation: 
ri-tux-i-mab
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Riabni
 - Rituxan
 - Riximyo 
 - Ruxience
 - Truxima
 
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "RiTUXimab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab. 
Vallerand AHA, Sanoski CAC,  . RiTUXimab. Davis's Drug Guide. F.A. Davis Company; 2025. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab. Accessed November 4, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). RiTUXimab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab
Vallerand AHA, Sanoski CAC,  . RiTUXimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 November 04]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  riTUXimab
ID  -  51672
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/51672/all/riTUXimab
PB  -  F.A. Davis Company
ET  -  19
DB  -  Pediatrics Central
DP  -  Unbound Medicine
ER  -  

Davis's Drug Guide

